The current valuation score of Zymeworks Inc is 8.78, ranking 89 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -17.02, which is -130.92% below the recent high of 5.26 and -98.29% above the recent low of -33.76.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.